CGEN logo

CGEN
Compugen Ltd

2,573
Mkt Cap
$208.02M
Volume
205,711.00
52W High
$2.38
52W Low
$1.13
PE Ratio
6.12
CGEN Fundamentals
Price
$2.26
Prev Close
$2.20
Open
$2.20
50D MA
$1.97
Beta
1.58
Avg. Volume
335,912.45
EPS (Annual)
$0.3767
P/B
2.08
Rev/Employee
$970,186.67
$0.8571
Loading...
Loading...
News
all
press releases
Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Truist Financial
Truist Financial upgraded Compugen to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates
Compugen (CGEN) delivered earnings and revenue surprises of +1,053.85% and +276.79%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Earnings Breakdown: Compugen Q4
read more...
Benzinga·1mo ago
News Placeholder
Compugen Reports Fourth Quarter and Full Year 2025 Results
Compugen Reports Fourth Quarter and Full Year 2025 Results Compugen Reports Fourth Quarter and Full Year 2025 Results PR Newswire HOLON, ISRAEL, March 2, 2026 Strengthened financial position through...
PR Newswire·1mo ago
News Placeholder
Uncovering Potential: Compugen's Earnings Preview
read more...
Benzinga·1mo ago
News Placeholder
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates
Kymera Therapeutics (KYMR) delivered earnings and revenue surprises of -25.83% and -84.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
Acadia (ACAD) delivered earnings and revenue surprises of +31.36% and -2.94%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Prothena (PRTA) Reports Q4 Loss, Lags Revenue Estimates
Prothena (PRTA) delivered earnings and revenue surprises of +1.12% and -99.30%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Compugen to Participate in Upcoming Investor Conferences
Compugen to Participate in Upcoming Investor Conferences Compugen to Participate in Upcoming Investor Conferences PR Newswire HOLON, Israel, Feb. 19, 2026 HOLON, Israel, Feb. 19, 2026 /PRNewswire...
PR Newswire·1mo ago
News Placeholder
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 PR Newswire HOLON...
PR Newswire·1mo ago
<
1
2
...
>

Latest CGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.